Electrosal™
Hartmann's Solution
Intravenous Infusion BP
Presentation
Electrosal™ 500 ml Intravenous Infusion: Each 100 ml solution contains Sodium Chloride BP 0.6 g, Potassium Chloride BP 0.04 g, Calcium Chloride Dihydrate BP 0.027 g and Sodium Lactate (as 50% Solution) BP 0.32 g.
Electrosal™ 1000 ml Intravenous Infusion: Each 100 ml solution contains Sodium Chloride BP 0.6 g, Potassium Chloride BP 0.04 g, Calcium Chloride Dihydrate BP 0.027 g and Sodium Lactate (as 50% Solution) BP 0.32 g.
Description
Electrosal™ w/v is a sterile & pyrogen free solution of Sodium Chloride, Potassium Chloride, Calcium Chloride (as Dihydrate) and Sodium Lactate (as 50% Solution) in Water for Injections.
Indications
Electrosal™ is used to treat hypovolemia caused by surgery, hemorrhage and trauma. Excessive sweating, severe diarrhoea or vomiting, excess loss of fluid by nephritic kidneys, inadequate intake of fluid and electrolytes etc. that may lead to typical hypovolemic shock may be corrected with Electrosal™. Severe plasma loss caused by intestinal obstruction, burns or other denuding conditions of the skin may be treated with Electrosal™. It is mainly used as a fluid and electrolyte replenisher. It may be used as an alternative to Sodium Bicarbonate in the treatment of metabolic acidosis associated with dehydration and to alkalinized urine
Dosage and Administration
The volume and rate of infusion will depend upon the requirements of the patients and the judgment of the physician. It usually varies with age, weight and clinical condition of the patient. The recommended flow rate is up to 100-drops/minute/70 kg body weight. In burn patients the dose of Hartmann's solution according to the Parkland formula: 4ml/kg body weight/% of Body surface area (BSA) burn (e.g. for a 30% BSAburn of a person having 60 kg body weight, 4 x 60 x 30ml = 7200 ml of Hartmann's solution would be required in 24 hours). Half of this within 8 hr, the remainder over 16 hr.
Side Effects
Tissue edema can develop when large volumes are used.
Contraindications
Do not use in patients with established renal failure.
Precautions & Warning
Hartmann's solution should not be administered rapidly or for prolonged periods. Since the solution contains different electrolytes, it should be infused with caution in patients where electrolyte imbalance may cause detrimental effects; e.g. in pregnancy, renal impairment, heart failure, pulmonary congestion, etc. or to patients receiving potassium sparing diuretics.
In Pregnancy: Pregnancy Category C. Infusion of fluid should be immediately discontinued if rigor arises for any reason during the process. Do not use if the solution is cloudy, contains particles, or after expiry date.
Pharmaceutical Precaution
Electrosal™ should be stored at controlled room temperature.
Commercial Pack
Electrosal™ 500 ml Intravenous Infusion: Available in 500 ml Polypropylene bag.
Electrosal™ 1000 ml Intravenous Infusion: Available in 1000 ml Polypropylene bag.
Administration Procedure
1. Check infusion set and infusion solution prior to use
2. Pull moderately to tear off the protective cover of the Eurohead (Picture-1)
3. Hold lightly the Eurohead but not the bag (Picture-2)
4. Open the flow regulator fully and hold the giving set on the top white
area, but not the membrane venting region (Picture-2)
5. Insert the spike of the administration set to the Eurohead and fit the
connector of the administration set firmly to the needle (Picture-2)
6. Gradually allow the fluid to flow down to the needle tip and close
7. Remove the protective cover of the needle
8. Locate the veinpuncture site and clean the site with an antiseptic
solution, and then insert the needle (Picture-3)
9. Securely tape the puncture site
10. Securely tape the wings and tubing
11. Start infusion while adjusting drip speed
